MEDX holdings

Holdings

#	Holding	Type	Weight	Value	Shares / par	Country
1	LLYEli Lilly & Co.	Equity	18.46%	$3.5M	2,936	US
2	US BANK MMDA - USBGFS 7	Cash	9.19%	$1.8M	1,752,681	US
3	ABBVABBVIE INC.	Equity	8.85%	$1.7M	6,712	US
4	NVSNovartis AG	Equity	6.89%	$1.3M	8,388	CH
5	JNJJohnson & Johnson	Equity	5.59%	$1.1M	4,200	US
6	Alkermes PLC	Equity	5.53%	$1.1M	20,132	IE
7	AstraZeneca PLC	Equity	4.98%	$951K	5,015	GB
8	IONSIonis Pharmaceuticals, Inc. Common Stock	Equity	4.53%	$865K	10,904	US
9	BMYBristol-Myers Squibb Co.	Equity	4.42%	$844K	14,644	US
10	MRKMerck & Co., Inc.	Equity	3.96%	$755K	5,872	US
11	AMGNAmgen Inc	Equity	3.91%	$747K	2,062	US
12	ALNYAlnylam Pharmaceuticals, Inc.	Equity	3.42%	$653K	2,168	US
13	BIIBBiogen Inc. Common Stock	Equity	3.09%	$589K	2,726	US
14	PFEPfizer Inc.	Equity	2.86%	$545K	22,648	US
15	GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	Equity	2.71%	$516K	9,846	GB
16	CRISPR Therapeutics AG	Equity	2.64%	$503K	9,228	CH
17	REGNRegeneron Pharmaceuticals Inc	Equity	2.06%	$393K	630	US
18	BEAMBeam Therapeutics Inc. Common Stock	Equity	1.51%	$288K	8,388	US
19	GALTGalectin Therapeutics Inc.	Equity	1.14%	$218K	46,968	US
20	NTLAIntellia Therapeutics, Inc	Equity	1.12%	$213K	12,584	US
21	SDZNYSANDOZ GROUP AG S/ADR	Equity	0.80%	$152K	1,680	CH
22	REPLReplimune Group, Inc.	Equity	0.73%	$139K	12,584	US
23	VNDAVanda Pharmaceuticals Inc.	Equity	0.73%	$139K	22,648	US
24	HLNHaleon plc American Depositary Shares (Each representing two Ordinary Shares)	Equity	0.60%	$115K	12,309	GB
25	LTRNLantern Pharma Inc. Common Stock	Equity	0.55%	$105K	25,164	US
26	EDITEditas Medicine, Inc. Common Stock	Equity	0.47%	$90K	27,680	US
27	GEHCGE HealthCare Technologies Inc. Common Stock	Equity	0.28%	$54K	840	US
28	BCYCBicycle Therapeutics plc American Depositary Shares	Equity	0.28%	$53K	12,584	GB
29	VTRSViatris Inc. Common Stock	Equity	0.26%	$50K	3,122	US
30	ALLOAllogene Therapeutics, Inc. Common Stock	Equity	0.18%	$35K	16,776	US
31	PACBPacific Biosciences of California, Inc.	Equity	0.09%	$17K	10,068	US
32	DCOYDecoy Therapeutics Inc. Common Stock	Equity	0.00%	$149	21	US
33	Pathos AI Inc	Equity	0.00%	$0	23,992	US

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Position changes between reports

Action	Holding	Weight before	Weight after	Shares vs flows	Between reports
New position	AstraZeneca PLC	—	5.71%	—	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	AZNAstraZeneca PLC	5.33%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC

Share-count changes are measured after removing what creations and redemptions explain.

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.